VANGUARD GROUP INC Q3 2018 Filing

Filed November 14, 2018

Portfolio Value

$2.6T

Holdings

4,126

Report Date

Q3 2018

Filing Type

13F-HR

All Holdings (4,126 positions)

StockValue
BIO-KEY INTERNATIONAL INC
$52K
NBYNOVABAY PHARMACEUTICALS INC
$51K
CHANTICLEER HLDGS INC
$51K
CELLECTAR BIOSCIENCES INC
$50K
STAFFING 360 SOLUTIONS INC
$46K
YOGAQYOGAWORKS INC
$45K
CAFEPRESS INC
$44K
CCA INDS INC
$43K
OGENORAGENICS INC
$43K
TIOGMICT INC
$41K
CHF SOLUTIONS INC
$39K
OXBROXBRIDGE RE HLDGS LTD
$37K
AMSAMERICAN DFND HOSPITAL SVC
$36K
RXI PHARMACEUTICALS CORP NEW
$35K
GNPXGENPREX INC
$33K
TRUETT-HURST INC
$31K
U S ENERGY CORP WYO
$29K
ARCA BIOPHARMA INC
$29K
MYOS RENS TECHNOLOGY INC
$27K
AWI1ALLIED HEALTHCARE PRODS INC
$25K
BLONDER TONGUE LABS INC
$20K
SUPERCONDUCTOR TECHNOLOGIES
$19K
MYND ANALYTICS INC
$18K
NEUROMETRIX INC
$16K
TPLUSDTEXAS PAC LD TR
$15K
LM FDG AMER INC
$6K
PreviousPage 42 of 42